J. Goldman & Co’s iRhythm Holdings IRTC Stock Holding History

J. Goldman & Co’s Portfolio IRTC Stock Details IRTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18,206	Closed	-$1.44M	–	319
2019 Q2	$1.44M	Buy	+18,206	New	+$1.33M	0.1%	174

Other funds holding IRTC

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

J. Goldman & Co's IRTC Position: Q3 2019 in Review

J. Goldman & Co sold out of iRhythm Holdings (IRTC) in Q3 2019, closing a stake of 18,206 shares — an estimated $1.44M sold.

J. Goldman & Co first reported a position in IRTC in Q2 2019 and held it in 1 quarter. The position peaked at $1.44M in Q2 2019. 168 funds tracked by Wall St. Rank hold IRTC as of Q3 2019.

J. Goldman & Co reported no remaining iRhythm Holdings position as of Q3 2019 after selling out during the quarter.
J. Goldman & Co sold 18,206 iRhythm Holdings shares in Q3 2019, an estimated $1.44M.
J. Goldman & Co first reported a position in iRhythm Holdings in Q2 2019 and held it in 1 quarter.
J. Goldman & Co's iRhythm Holdings position peaked at $1.44M in Q2 2019.
168 funds tracked by Wall St. Rank held iRhythm Holdings as of Q3 2019.

Based on J. Goldman & Co's 13F filing for Q3 2019, filed 14 Nov 2019.